MaaT Pharma Receives Negative CHMP Trend Vote for MaaT013 (Xervyteg®) Following Re-Examination for its Conditional Marketing Authorization Application in Europe
This press release is being prepared.
The market announcement is already indexed, but the document has not finished syncing to our storage yet.